Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person8
June Baker
Person
BAKER JOHN D II
Company
Alan R Baker
Person
Baker Roger A
Company
Baker John D. III
Company
Rita A Baker
Person
BAKER DANIEL A
Company
Thomas E Baker
Person
Primary record20
BAKER BROS. ADVISORS LP filed SCHEDULE 13D/A
("SEC") on November 3, 2026 plus (i) 90,417 shares of Common Stock that may be acquired upon exercise of 90,417 Prefunded Warrants (as defined below), subject to the limitations on exercise of the Prefunded Warrants as d
LANTRONIX INC filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The Board of Directors of Lantronix, Inc. (the “Company”) prev
Ocean Power Technologies, Inc. filed 8-K
Item 4.01. Change in Registrant’s Certifying Accountant. (a) Dismissal of Previous Independent Registered Public Accounting Firm . Effective June 2, 2025, Moss Adams LLP (“Moss Adams”), our independent registered public
HINES GLOBAL INCOME TRUST, INC. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 2, 2026, Hines Interests Limited Partnership ( Hines
Vivos Therapeutics, Inc. filed 8-K
Item 4.01 Changes in Registrant s Certifying Accountant. (a) Dismissal of Independent Registered Public Accounting Firm On September 29, 2026, the Audit Committee (the Audit Committee ) of the Board of Directors of Vivos
Kodiak Sciences Inc. filed SCHEDULE 13D/A
("SEC") on August 13, 2026 plus 188,356 vested non-qualified options exercisable for 188,356 shares of Common Stock ("Stock Options") received by Felix J. Baker as compensation for his service on the Board. Set forth in
Hepion Pharmaceuticals, Inc. filed 8-K
Item 4.01 Changes in Registrant s Certifying Accountant. On September 21, 2026, the audit committee of the Board of Directors of Hepion Pharmaceuticals, Inc. (the Company ) approved the dismissal of Grassi & Co., CPAs, P
Benitec Biopharma Inc. filed 8-K
Item 4.01 Changes in Registrant s Certifying Accountant. Baker Tilly US, LLP ( Baker Tilly ), the Company s independent registered public accounting firm, has served as the Company s auditor since 2020. As a matter of go
La Rosa Holdings Corp. filed 8-K
Item 4.01. Changes in Registrant s Certifying Accountant. On September 16, 2026, the Audit Committee (the Committee ) of the Board of Directors of La Rosa Holdings Corp., a Nevada corporation (the Company ), dismissed CB
Net Power Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. On September 8, 2026 (the Suspension Date ), Net Power, LLC ( NET Power ), a Delaware limited liability company and an indirect subsidiary of NET Power Inc. (the Comp
Factorial Energy Inc. filed SCHEDULE 13G/A
0001688382-26-000023.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001688382-26-000004 0001688382 XXXXXXXX LIVE 1 Series A Common Stock, par value $0.00001 per share 06/30/2026 0002049662 Factoria
BAKER BROS. ADVISORS LP filed SCHEDULE 13G
, as amended, no more than 4.99% of the outstanding Common Stock (the "Maximum Percentage"). By written notice to the Issuer, the Funds may from time to time increase or decrease the Maximum Percentage applicable to that
Cerebras Systems Inc. filed SCHEDULE 13G
(the "SEC"), which serves as the investment manager (the "Investment Manager") to certain investment funds and/or accounts (the "Funds"), with respect to the shares of Class A Common Stock (as defined in Item 2(d) below)
Fort Baker Capital Management LP filed SCHEDULE 13G/A
on June 26, 2026, in which the Issuer stated that the number of Class A Ordinary Shares outstanding was 14,159,633 as of June 26, 2026. Fort Baker Capital Management LP: 8.9% Steven Patrick Pigott: 8.9% Fort Baker Capita
PETMED EXPRESS INC filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 11, 2026, the shareholders of PetMed Express, Inc. (th
BAKER BROS. ADVISORS LP filed SCHEDULE 13D/A
("SEC") on June 29, 2026 plus 9,701,490 shares of Common Stock issued at the close of the Offering plus 30,000 shares of Common Stock underlying Stock Options (as defined below) held directly by Michael Goller that are e
NVE CORP /NEW/ filed 8-K
Item 5.07 Submission of Matters to a Vote of Security Holders. Our 2026 Annual Meeting of Shareholders was held August 6, 2026, for the following purposes: (1) elect seven directors; (2) advisory approval of named execut
Rocky Mountain Chocolate Factory, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 3, 2026, Rocky Mountain Chocolate Factory, Inc. (the
Liberal Democrats accepted £21,855.03 from June Baker
Liberal Democrats reported accepting £21,855.03 from June Baker. Donor status: Individual. Type: Cash. Accepted 15/01/2026.
Liberal Democrats accepted £21,855.03 from June Baker
Liberal Democrats reported accepting £21,855.03 from June Baker. Donor status: Individual. Type: Cash. Accepted 14/01/2026.